These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 2044328)

  • 1. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions with phenytoin (Part I).
    Nation RL; Evans AM; Milne RW
    Clin Pharmacokinet; 1990 Jan; 18(1):37-60. PubMed ID: 2178849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.
    Norberg A; Jones AW; Hahn RG; Gabrielsson JL
    Clin Pharmacokinet; 2003; 42(1):1-31. PubMed ID: 12489977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturable first-pass kinetics of propranolol.
    Keller F; Kunzendorf U; Walz G; Haller H; Offermann G
    J Clin Pharmacol; 1989 Mar; 29(3):240-5. PubMed ID: 2723110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic optimisation of anticonvulsant therapy.
    Thomson AH; Brodie MJ
    Clin Pharmacokinet; 1992 Sep; 23(3):216-30. PubMed ID: 1511537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady state phenytoin concentration.
    Ludden TM; Allerheiligen SR; Browne TR; Koup JR
    Ther Drug Monit; 1991 Mar; 13(2):120-5. PubMed ID: 2053118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
    Donnelly R; Macphee GJ
    Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.
    Cheng HY; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(5):513-28. PubMed ID: 2804255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
    Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
    Br J Clin Pharmacol; 1999 Jan; 47(1):53-8. PubMed ID: 10073740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
    O'Connor P; Feely J
    Clin Pharmacokinet; 1987 Dec; 13(6):345-64. PubMed ID: 3325214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.